Aggregated α-synuclein and complex I deficiency: Exploration of their relationship in differentiated neurons

Cell Death and Disease

Volumn 6, Issue 7, 2015, Pages

  Reeve, A K ^a   Ludtmann, M H R ^b   Angelova, P R ^b   Simcox, E M ^a   Horrocks, M H ^c   Klenerman, D ^c   Gandhi, S ^b   Turnbull, D M ^a   Abramov, A Y ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; CYTOCHROME C OXIDASE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; COMPLEX I DEFICIENCY; CONTROLLED STUDY; CYTOCHROME C OXIDASE DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HYBRID CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTATION; NERVE CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; ANIMAL; DEFICIENCY; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOUSE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOLOGY; PROTEINOSIS;

ALPHA-SYNUCLEIN; ANIMALS; ELECTRON TRANSPORT COMPLEX I; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN AGGREGATION, PATHOLOGICAL; REACTIVE OXYGEN SPECIES;

EID: 84954311788     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.166     Document Type: Article

References (38)

1. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho W.H., Castillo PE et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000; 25: 239-252.
2. Burre J, Sharma M, Tsetsenis T, Buchman V., Etherton MR, Sudhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science New York, NY 2010; 329: 1663-1667.
3. Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005; 123: 383-396.
4. Garcia-Reitbock P., Anichtchik O, Bellucci A, Iovino M., Ballini C, Fineberg E et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 2010; 133(Pt 7): 2032-2044.
5. Bellucci A, Zaltieri M, Navarria L, Grigoletto J., Missale C, Spano P. From alpha-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease. Brain Res 2012; 1476: 183-202.
6. Cheng F, Vivacqua G, Yu S. The role of alpha-synuclein in neurotransmission and synaptic plasticity. J Chem Neuroanat 2011; 42: 242-248.
7. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 2000; 20: 3214-3220.
8. Bendor JT, Logan TP, Edwards RH. The function of alpha-synuclein. Neuron 2013; 79: 1044-1066.
9. Devi L, Raghavendran V, Prabhu BM, Avadhani N.G., Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 2008; 283: 9089-9100.
10. Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 1998; 273: 9443-9449.
11. Jensen MB, Bhatia VK, Jao CC, Rasmussen J.E., Pedersen SL, Jensen KJ et al. Membrane curvature sensing by amphipathic helices: a single liposome study using alpha-synuclein and annexin B12. J Biol Chem 2011; 286: 42603-42614.
12. Parihar MS, Parihar A, Fujita M, Hashimoto M., Ghafourifar P. Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci 2008; 65: 1272-1284.
13. Luth ES, Stavrovskaya IG, Bartels T, Kristal BS, Selkoe DJ. Soluble, prefibrillar alpha-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction. J Biol Chem 2014; 289: 21490-21507.
14. Bender A, Krishnan KJ, Morris CM, Taylor G.A., Reeve AK, Perry RH et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006; 38: 515-517.
15. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall N.W., Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006; 38: 518-520.
16. Abramov AY, Smulders-Srinivasan TK, Kirby DM, Acin-Perez R, Enriquez J.A., Lightowlers RN et al. Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations. Brain 2010; 133(Pt 3): 797-807.
17. Cremades N, Cohen SI, Deas E, Abramov AY, Chen A.Y., Orte A et al. Direct observation of the interconversion of normal and toxic forms of alpha-synuclein. Cell 2012; 149: 1048-1059.
18. Plun-Favreau H., Burchell VS, Holmstrom KM, Yao Z, Deas E., Cain K et al. HtrA2 deficiency causes mitochondrial uncoupling through the F(1) F(0)-ATP synthase and consequent ATP depletion. Cell Death Dis 2012; 3: e335.
19. Imamura H, Noji H. [Imaging of intracellular ATP using novel fluorescent probes]. Tanpakushitsu kakusan koso Protein, nucleic acid, enzyme 2009; 54: 1937-1944.
20. Kovac S, Domijan AM, Walker MC, Abramov AY. Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death. J Cell Sci. 2012; 125(Pt 7): 1796-1806.
21. Angelova PR, Horrocks MH, Klenerman D, Gandhi S, Abramov A.Y., Shchepinov MS. Lipid peroxidation is essential for alpha-synuclein-induced cell death. J Neurochem 2015; 133: 582-589.
22. Bilan DS, Pase L, Joosen L, Gorokhovatsky A.Y., Ermakova YG, Gadella TW et al. HyPer-3: a genetically encoded H(2) O(2) probe with improved performance for ratiometric and fluorescence lifetime imaging. ACS Chem Biol 2013; 8: 535-542.
23. Martin LJ, Pan Y, Price AC, Sterling W, Copeland N.G., Jenkins NA et al. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 2006; 26: 41-50.
24. Martin LJ, Semenkow S, Hanaford A, Wong M. The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant alpha-synuclein transgenic mice. Neurobiol Aging 2014; 35: 1132-1152.
25. Zhu Y, Duan C, Lu L, Gao H., Zhao C, Yu S et al. Alpha-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator. Int J Biochem Cell Biol 2011; 43: 732-741.
26. Subramaniam SR, Vergnes L, Franich NR, Reue K, Chesselet MF. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein. Neurobiol Dis 2014; 70: 204-213.
27. Bender A, Desplats P, Spencer B, Rockenstein E., Adame A, Elstner M et al. TOM40 mediates mitochondrial dysfunction induced by alpha-synuclein accumulation in Parkinson's disease. PLoS One 2013; 8: e62277.
28. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy J.M., Egami K et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 2011; 286: 20710-20726.
29. Botella JA, Bayersdorfer F, Schneuwly S. Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease. Neurobiol Dis 2008; 30: 65-73.
30. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000; 3: 1301-1306.
31. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (New York, NY) 1983; 219: 979-980.
32. Langston JW, Ballard PA Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983; 309: 310.
33. Vivacqua G, Biagioni F, Yu S, Casini A., Bucci D, D'Este L et al. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice. J Chem Neuroanat 2012; 44: 76-85.
34. Jethva PN, Kardani JR, Roy I. Modulation of alpha-synuclein aggregation by dopamine in the presence of MPTP and its metabolite. FEBS J 2011; 278: 1688-1698.
35. Kirby DM, Rennie KJ, Smulders-Srinivasan TK, Acin-Perez R, Whittington M, Enriquez JA et al. Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation. Cell Prolif 2009; 42: 413-424.
36. Bain G, Kitchens D, Yao M, Huettner J.E., Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995; 168: 342-357.
37. Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J 2011; 435: 297-312.
38. Brand MD. The efficiency and plasticity of mitochondrial energy transduction. Biochem Soc Trans 2005; 33(Pt 5): 897-904.